Curatis Holding AG | WebDisclosure

Basculer en Français

11243	Companies
249510	Keywords
177604	Articles
135336	Press releases

Home
Companies
Curatis Holding AG

PRESS RELEASE

published on 09/16/2024 at 07:00, 2 years 1 month ago

Curatis: Deutlich gesteigerter Umsatz im Kerngeschäft und Projekte in Entwicklungs-Pipeline auf Kurs
Curatis Holding AG reports significantly increased revenue in core business and projects in development pipeline on track. Strong financial position and growth prospects highlighted in H1 2024 results

Financial Results Pharmaceutical Industry Revenue Business Development Curatis Holding AG
BRIEF

published on 09/12/2024 at 19:51, 2 years 1 month ago

Curatis Holding AG présentera ses résultats du premier semestre à Investora

Rapport Semestriel Soumission À La FDA Médicaments Orphelins Curatis Holding Conférence Investora
BRIEF

published on 09/12/2024 at 19:51, 2 years 1 month ago

Curatis Holding AG to Present at Investora and Release H1 Report Early

Half-year Report Orphan Drugs FDA Submission Curatis Holding Investora Conference
PRESS RELEASE

published on 09/12/2024 at 19:46, 2 years 1 month ago

Teilnahme an der Investora am 19. September 2024 und frühere Publikation des Halbjahresreports am 16. September
Curatis Holding to participate in Investora on September 19, 2024, and release half-year report on September 16. Key executives to present the company at the conference

Conference Orphan Drugs Pharma Curatis Holding Investora
BRIEF

published on 08/27/2024 at 17:50, 2 years 2 months ago

Curatis sur la bonne voie : soumet une demande d'autorisation de mise sur le marché de médicaments orphelins pour un produit candidat clé aux États-Unis

Curatis Médicament Orphelin La FDA Tumeur Cérébrale Pédiatrique
BRIEF

published on 08/27/2024 at 17:50, 2 years 2 months ago

Curatis on Track: Submits Orphan Drug Application for Key Product Candidate in the US

FDA Curatis Orphan Drug Brain Tumor Pediatric
PRESS RELEASE

published on 08/27/2024 at 17:45, 2 years 2 months ago

Curatis auf Kurs: Einreichung des Antrags für Orphan-Drug-Designation des wichtigsten Produktkandidaten in den USA
Curatis Holding AG submits application for Orphan Drug Designation of lead product candidate C-PBTE-01 in the USA, targeting rare brain tumors affecting children

Orphan Drug Designation Rare Disease Curatis Holding AG C-PBTE-01 Childhood Cancer
BRIEF

published on 07/25/2024 at 07:05, 2 years 3 months ago

Curatis Holding AG : Initiation de la couverture par valuationLAB

Curatis Recherche Sur Les Actions C-PTBE-01 ÉvaluationLAB Médicaments Orphelins
BRIEF

published on 07/25/2024 at 07:05, 2 years 3 months ago

Curatis Holding AG: Initiation of Coverage by valuationLAB

Curatis Equity Research Orphan Drugs ValuationLAB C-PTBE-01
PRESS RELEASE

published on 07/25/2024 at 07:00, 2 years 3 months ago

Curatis Holding AG: Initiation of Coverage and Publication of Equity Research Report by valuationLAB
Curatis Holding AG has initiated coverage and published an equity research report by valuationLAB estimating a risk-adjusted net present value of CHF 20.00 per share, signaling an enterprise value of CHF 103 million

Initiation Of Coverage Curatis Holding AG ValuationLAB Equity Research Report CHF 20.00 Per Share

Accesswire

Published on 10/28/2026 at 22:35, 5 hours 4 minutes ago

Route1 Announces Third Quarter and Year to Date 2026 Financial Results Notification
Published on 10/28/2026 at 12:30, 15 hours 9 minutes ago

Digi Power X to Announce 2026 Q3 Financial Results and Provide Operations Update on November 13th
Published on 10/28/2026 at 12:30, 15 hours 9 minutes ago

AI/ML Innovations Announces Advance Notice Provisions
Published on 10/28/2026 at 12:30, 15 hours 9 minutes ago

Sterling Expands Mineralized Footprint to 2km With Near Surface Intercept in 850m Eastern Step Out
Published on 10/28/2026 at 12:30, 15 hours 9 minutes ago

Ameriwest Reports Additional High-Grade Copper Results from Historical Drill Core at Bornite Including 71.0 Feet (21.6 Meters) at 8.08% CuEq

View all ACCESSWIRE

EQS Group

Published on 10/29/2026 at 00:15, 3 hours 24 minutes ago

Infinite Electronics Showcases Engineered Connectivity Solutions at electronica 2026
Published on 10/28/2026 at 21:35, 6 hours 4 minutes ago

Food & Beverage Manufacturers Race to Scale AI Beyond the Pilot Stage
Published on 10/28/2026 at 21:15, 6 hours 24 minutes ago

Amrize Reports Third Quarter 2026 Results
Published on 10/28/2026 at 21:15, 6 hours 24 minutes ago

Amrize Completes $1 Billion Share Repurchase Program
Published on 10/28/2026 at 20:36, 7 hours 2 minutes ago

Vonovia’s Core Business Remains Resilient as Higher Financing Costs and Weaker Transaction Business Shape 2027 Guidance and 2028 Objectives

Les Echos

Published on 10/28/2026 at 18:09, 9 hours 29 minutes ago

Mandat de rachat d’actions
Published on 10/28/2026 at 18:09, 9 hours 29 minutes ago

Share buyback mandate
Published on 10/28/2026 at 17:56, 9 hours 43 minutes ago

OPR - Mise à disposition de l'addendum au rapport d'expertise indépendante
Published on 10/28/2026 at 17:45, 9 hours 54 minutes ago

VOGO obtains FIBA (International Basketball Federation) Approval for its Instant Replay System.
Published on 10/28/2026 at 17:45, 9 hours 54 minutes ago

Successful issue of a € 6.0 billion bond as part of the financing of the PTC acquisition

View all LES ECHOS COMFI WIRE